LLY-283
目录号: A19754
PRMT5 inhibitor
LLY-283 是一种强效、选择性的口服 蛋白精氨酸甲基转移酶5 (PRMT5) 抑制剂，对 PRMT5:MEP50 复合体的 IC50 为 22 nM，Kd 为 6 nM，并显示出抗肿瘤活性。
顾客使用 Adooq 产品发表的高质量科研文献
生物活性
| Discription | LLY-283 is a potent, selective and oral protein arginine methyltransferase 5 (PRMT5) inhibitor, with an IC50 of 22 nM and a Kd of 6 nM for PRMT5:MEP50 complex, and shows antitumor activity. | |||||
|---|---|---|---|---|---|---|
| Cell Research |
|
产品信息
| 目录号 | A19754 |
|---|---|
| 分子式 | C17H18N4O4 |
| 分子量 | 342.35 |
| CAS号 | 2040291-27-6 |
| SMILES | O[C@H]1[C@@H](O[C@@]([C@@H](C2=CC=CC=C2)O)([H])[C@H]1O)N3C4=NC=NC(N)=C4C=C3 |
| 其他名称 | LLY283, LLY 283 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
溶解性数据
| In vitro | DMSO | 64 mg/mL (186.94 mM) | |
| Water | 5 mg/mL (14.6 mM) | ||
| Ethanol | 3 mg/mL (8.76 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
Preparing Stock Solutions
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 29.21 mL | 146.05 mL | 292.1 mL |
| 0.5 mM | 5.84 mL | 29.21 mL | 58.42 mL |
| 1 mM | 2.92 mL | 14.6 mL | 29.21 mL |
| 5 mM | 0.58 mL | 2.92 mL | 5.84 mL |
Useful Calculator
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
Keywords: 购买 LLY-283 | LLY-283 供应商 | LLY-283 花费 | LLY-283 生产商 | 订购 LLY-283 | LLY-283 代理商
| 购买 2040291-27-6 | 2040291-27-6 供应商 | 2040291-27-6 花费 | 2040291-27-6 生产商 | 订购 2040291-27-6 | 2040291-27-6 代理商